financetom
Business
financetom
/
Business
/
Massachusetts regulator probes 'Roaring Kitty's' GameStop trades
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Massachusetts regulator probes 'Roaring Kitty's' GameStop trades
Jun 4, 2024 8:30 AM

NEW YORK (Reuters) - The Massachusetts securities regulator is probing the trading activities of GameStop ( GME ) investor Keith Gill, who gained notoriety as stocks influencer "Roaring Kitty" during the 2021 meme stock frenzy.

Massachusetts Secretary of State Bill Galvin, the state's top securities regulator, is looking into Gill's activities, a spokesperson said, declining to comment further.

The Wall Street Journal first reported the inquiry.

GameStop ( GME ) shares surged on Monday after the stocks influencer "Roaring Kitty" returned to Reddit with a post showing a $116 million bet on the embattled videogame retailer.

Shares were down about 5% by 10:45 a.m. ET (1445 GMT).

The post, the first from the account in three years, also indicated that Gill may be sitting on a paper profit of tens of millions of dollars on his position in GameStop ( GME ) options.

Reuters was unable to independently verify if the Reddit post was made by Gill or if the positions disclosed were authentic.

Gill could not be reached immediately for comment. Regulatory inquiries and probes do not necessarily indicate wrongdoing and frequently do not result in any enforcement action.

Galvin had probed Gill's 2021 activities but closed that matter after bringing a settlement with Gill's former employer MassMutual for failing to properly supervise his activities, the spokesperson told Reuters last month.

In 2021, screenshots on Reddit of his bullish GameStop ( GME ) trades triggered a rush of demand for "meme stocks" - often companies with weak fundamentals that gained a cult-like following through social media hype among retail traders.

The U.S. Securities and Exchange Commission investigated the meme stock craze of 2021, ultimately finding that marketplace systems worked well and failing to find evidence that short sellers were behind the frenzy as retail investors had alleged.

The WSJ also reported that the SEC is looking at options trading in GameStop ( GME ). A spokesperson for the agency declined to confirm or comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Huntington Bancshares to Acquire Veritex for $1.9 Billion
Huntington Bancshares to Acquire Veritex for $1.9 Billion
Jul 14, 2025
08:30 AM EDT, 07/14/2025 (MT Newswires) -- Huntington Bancshares ( HBAN ) has entered into an agreement to acquire Veritex ( VBTX ) in an all-stock deal valued at $1.9 billion, the companies said Monday. Under the terms of the deal, Huntington will issue 1.95 shares for each outstanding share of Veritex ( VBTX ). The consideration implies $33.91 per...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Avalon GloboCare Receives Hong Kong Patent for Advanced CAR-T, CAR-NK Cell Technology
Avalon GloboCare Receives Hong Kong Patent for Advanced CAR-T, CAR-NK Cell Technology
Jul 14, 2025
08:32 AM EDT, 07/14/2025 (MT Newswires) -- Avalon GloboCare ( ALBT ) said Monday it granted a new standard patent in Hong Kong for its proprietary CAR-T and CAR-Natural Killer cell technology. The company said the patent for the technology, co-developed with Hong Kong-based partner Arbele, is valid for 20 years, starting Feb. 21, 2020. The patented technology would boost...
Corcept Therapeutics Files New Drug Application for Treatment of Platinum-Resistant Ovarian Cancer
Corcept Therapeutics Files New Drug Application for Treatment of Platinum-Resistant Ovarian Cancer
Jul 14, 2025
08:30 AM EDT, 07/14/2025 (MT Newswires) -- Corcept Therapeutics ( CORT ) said Monday that it has filed a New Drug Application with the US Food and Drug Administration for its selective cortisol modulator relacorilant to treat patients with platinum-resistant ovarian cancer. The filing is based on the results of the treatment's pivotal late-stage and mid-stage trials, which showed that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved